Crinetics Pharmaceuticals (CRNX) Accumulated Depreciation & Amortization: 2017-2025
Historic Accumulated Depreciation & Amortization for Crinetics Pharmaceuticals (CRNX) over the last 8 years, with Sep 2025 value amounting to $7.0 million.
- Crinetics Pharmaceuticals' Accumulated Depreciation & Amortization rose 0.90% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year increase of 38.91%. This contributed to the annual value of $7.7 million for FY2024, which is 52.57% up from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $7.0 million for Q3 2025, which was down 26.53% from $9.6 million recorded in Q2 2025.
- Crinetics Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $9.6 million for Q2 2025, and its period low was $2.9 million during Q1 2021.
- In the last 3 years, Crinetics Pharmaceuticals' Accumulated Depreciation & Amortization had a median value of $6.2 million in 2024 and averaged $6.4 million.
- Data for Crinetics Pharmaceuticals' Accumulated Depreciation & Amortization shows a peak YoY spiked of 57.72% (in 2025) over the last 5 years.
- Crinetics Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $3.5 million in 2021, then climbed by 17.36% to $4.1 million in 2022, then rose by 24.09% to $5.1 million in 2023, then soared by 52.57% to $7.7 million in 2024, then grew by 0.90% to $7.0 million in 2025.
- Its last three reported values are $7.0 million in Q3 2025, $9.6 million for Q2 2025, and $8.6 million during Q1 2025.